electroCore (ECOR) Competitors $5.13 -0.08 (-1.59%) Closing price 03:59 PM EasternExtended Trading$5.09 -0.04 (-0.72%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ECOR vs. BSGM, LNSR, RCEL, AVR, LAKE, MBOT, PDEX, PROF, LUCD, and HYPRShould you be buying electroCore stock or one of its competitors? The main competitors of electroCore include Biosig Technologies (BSGM), LENSAR (LNSR), Avita Medical (RCEL), Anteris Technologies Global (AVR), Lakeland Industries (LAKE), Microbot Medical (MBOT), Pro-Dex (PDEX), Profound Medical (PROF), Lucid Diagnostics (LUCD), and Hyperfine (HYPR). These companies are all part of the "medical equipment" industry. electroCore vs. Its Competitors Biosig Technologies LENSAR Avita Medical Anteris Technologies Global Lakeland Industries Microbot Medical Pro-Dex Profound Medical Lucid Diagnostics Hyperfine Biosig Technologies (NASDAQ:BSGM) and electroCore (NASDAQ:ECOR) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, institutional ownership, earnings, media sentiment, profitability and risk. Do analysts recommend BSGM or ECOR? Biosig Technologies presently has a consensus target price of $10.00, indicating a potential upside of 99.80%. electroCore has a consensus target price of $25.50, indicating a potential upside of 397.37%. Given electroCore's higher probable upside, analysts clearly believe electroCore is more favorable than Biosig Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Biosig Technologies 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00electroCore 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media prefer BSGM or ECOR? In the previous week, Biosig Technologies had 4 more articles in the media than electroCore. MarketBeat recorded 4 mentions for Biosig Technologies and 0 mentions for electroCore. electroCore's average media sentiment score of 0.97 beat Biosig Technologies' score of -0.23 indicating that electroCore is being referred to more favorably in the news media. Company Overall Sentiment Biosig Technologies Neutral electroCore Positive Is BSGM or ECOR more profitable? Biosig Technologies has a net margin of 0.00% compared to electroCore's net margin of -47.84%. electroCore's return on equity of -221.93% beat Biosig Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Biosig TechnologiesN/A -10,930.60% -90.03% electroCore -47.84%-221.93%-69.17% Do institutionals & insiders believe in BSGM or ECOR? 7.2% of Biosig Technologies shares are held by institutional investors. Comparatively, 26.7% of electroCore shares are held by institutional investors. 24.8% of Biosig Technologies shares are held by insiders. Comparatively, 13.8% of electroCore shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Which has more volatility and risk, BSGM or ECOR? Biosig Technologies has a beta of 1.65, indicating that its stock price is 65% more volatile than the S&P 500. Comparatively, electroCore has a beta of 0.27, indicating that its stock price is 73% less volatile than the S&P 500. Which has preferable earnings and valuation, BSGM or ECOR? Biosig Technologies has higher earnings, but lower revenue than electroCore. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBiosig Technologies$40K3,931.43-$10.33MN/AN/AelectroCore$25.18M1.54-$11.89M-$1.62-3.16 SummaryelectroCore beats Biosig Technologies on 7 of the 13 factors compared between the two stocks. Get electroCore News Delivered to You Automatically Sign up to receive the latest news and ratings for ECOR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ECOR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ECOR vs. The Competition Export to ExcelMetricelectroCoreMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$38.86M$2.49B$5.74B$9.56BDividend YieldN/A1.66%4.53%4.07%P/E Ratio-3.1622.4730.4325.14Price / Sales1.54549.48392.4187.63Price / CashN/A173.7937.0358.50Price / Book34.185.278.956.21Net Income-$11.89M$31.83M$3.26B$265.38M7 Day Performance-2.16%0.85%1.03%-1.12%1 Month Performance-27.79%3.72%4.28%-0.68%1 Year Performance-15.54%9.51%28.38%18.92% electroCore Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ECORelectroCore2.676 of 5 stars$5.13-1.6%$25.50+397.4%-14.4%$38.86M$25.18M-3.1650Gap DownBSGMBiosig Technologies1.9499 of 5 stars$5.48+10.3%$10.00+82.5%+995.1%$156.15M$40K0.0050Earnings ReportGap DownHigh Trading VolumeLNSRLENSAR1.0414 of 5 stars$12.75+0.8%$15.00+17.6%+209.1%$150.98M$53.49M-3.03110Positive NewsRCELAvita Medical1.445 of 5 stars$5.55-1.4%$12.40+123.4%-47.1%$149.87M$64.25M-2.82130News CoverageAVRAnteris Technologies GlobalN/A$3.80-5.9%$16.50+334.2%N/A$145.69M$2.70M0.00138LAKELakeland Industries4.1483 of 5 stars$15.06+0.6%$26.00+72.6%-38.0%$142.43M$167.21M-5.002,100MBOTMicrobot Medical1.8661 of 5 stars$3.08-0.3%$9.00+192.2%+221.4%$140.74MN/A-5.3120News CoverageOptions VolumePDEXPro-Dex1.6783 of 5 stars$44.10+3.2%$56.00+27.0%+124.3%$139.34M$64.12M15.75140PROFProfound Medical1.7719 of 5 stars$4.75+11.8%$11.00+131.6%-51.1%$127.73M$10.68M-3.25150Earnings ReportHigh Trading VolumeLUCDLucid Diagnostics1.9574 of 5 stars$1.02flat$3.55+248.0%+22.3%$110.65M$4.35M-0.8670Gap DownHYPRHyperfine1.5453 of 5 stars$1.29-7.2%$1.28-0.5%+22.5%$108.19M$12.89M-2.48190Analyst Revision Related Companies and Tools Related Companies BSGM Competitors LNSR Competitors RCEL Competitors AVR Competitors LAKE Competitors MBOT Competitors PDEX Competitors PROF Competitors LUCD Competitors HYPR Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ECOR) was last updated on 8/21/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding electroCore, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share electroCore With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access